Targeting kinases regulating nucleic acid sensor activities like Akt is also feasible—Akt inhibition suppresses tumor growth not only through intrinsic survival mechanisms but also through releasing Akt-mediated cGAS suppression to facilitate innate immune activation and subsequent increased immune cell infiltrates, which warrants further investigations. The gene discussed is AKT1; the disease is neoplasm.